Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Gene expression markers and treatment of multiple sclerosis

Gene expression markers and treatment of multiple sclerosis

US Patent 12098426 · Granted Sep 24, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Diagnostic and therapeutic methods for the treatment of rheumatoid arthritis (RA2025
Anti-tryptase antibodies, compositions thereof, and uses thereof2024
Therapeutic and diagnostic methods for IL-33-mediated disorders2023
Gene expression markers and treatment of multiple sclerosis2022
Gene expression markers and treatment of multiple sclerosis2022
Gene expression markers and treatment of multiple sclerosis2022
Anti-tryptase antibodies, compositions thereof, and uses thereof2020
Anti-tryptase antibodies, compositions thereof, and uses thereof2020
Biological markers and methods for predicting response to B-cell antagonists2018
Methods for treating, diagnosing, and monitoring rheumatoid arthritis2017
Methods for diagnosing and treating systemic lupus erythematosus2015
Methods for detecting and treating systemic lupus erythematous2015